BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30659523)

  • 1. Re-irradiation in elderly patients with glioblastoma: a single institution experience.
    Straube C; Antoni S; Gempt J; Zimmer C; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
    J Neurooncol; 2019 Apr; 142(2):327-335. PubMed ID: 30659523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
    Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
    J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.
    Bräutigam E; Lampl C; Track C; Nieder C; Pichler J; Hammer J; Geinitz H
    Clin Transl Oncol; 2019 May; 21(5):582-587. PubMed ID: 30284233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.
    Combs SE; Gutwein S; Thilmann Ch; Huber P; Debus J; Schulz-Ertner D
    J Neurooncol; 2005 Sep; 74(2):167-71. PubMed ID: 16193388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report.
    Pashaki AS; Hamed EA; Mohamadian K; Abassi M; Safaei AM; Torkaman T
    Asian Pac J Cancer Prev; 2014; 15(6):2793-6. PubMed ID: 24761902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
    Baehr A; Trog D; Oertel M; Welsch S; Kröger K; Grauer O; Haverkamp U; Eich HT
    Strahlenther Onkol; 2020 May; 196(5):457-464. PubMed ID: 32016497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
    Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
    J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.
    You WC; Lee HD; Pan HC; Chen HC
    Sci Rep; 2023 Jun; 13(1):9442. PubMed ID: 37296207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
    Schnell O; Thorsteinsdottir J; Fleischmann DF; Lenski M; Abenhardt W; Giese A; Tonn JC; Belka C; Kreth FW; Niyazi M
    J Neurooncol; 2016 Dec; 130(3):591-599. PubMed ID: 27599828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.
    Gerstein J; Franz K; Steinbach JP; Seifert V; Fraunholz I; Weiss C; Rödel C
    Radiother Oncol; 2010 Dec; 97(3):382-6. PubMed ID: 20850883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
    Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
    Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
    J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.